A detailed history of Golden State Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 1,832 shares of AMGN stock, worth $520,324. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,832
Previous 1,916 4.38%
Holding current value
$520,324
Previous $463,000 103060.04%
% of portfolio
0.07%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

SELL
$258.78 - $328.31 $21,737 - $27,578
-84 Reduced 4.38%
1,832 $478 Million
Q1 2022

May 19, 2022

BUY
$219.27 - $242.57 $14,033 - $15,524
64 Added 3.46%
1,916 $463,000
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $211,595 - $234,080
-965 Reduced 34.26%
1,852 $461,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $152,938 - $175,024
769 Added 37.55%
2,817 $634,000
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $16,557 - $19,398
78 Added 3.96%
2,048 $436,000
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $27,562 - $30,578
118 Added 6.37%
1,970 $480,000
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $233,449 - $272,047
-1,052 Reduced 36.23%
1,852 $461,000
Q4 2020

Jan 28, 2021

BUY
$216.38 - $257.67 $230,877 - $274,933
1,067 Added 58.08%
2,904 $668,000
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $204,849 - $227,809
-873 Reduced 32.21%
1,837 $467,000
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $536,065 - $657,825
2,710 New
2,710 $639,000
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $352,299 - $432,319
-1,781 Closed
0 $0
Q1 2020

Apr 17, 2020

BUY
$182.24 - $241.7 $324,569 - $430,467
1,781 New
1,781 $361,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Golden State Wealth Management, LLC Portfolio

Follow Golden State Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Wealth Management, LLC with notifications on news.